In re Oracle Corporation Deriv. Litig.

Delaware Court of Chancery · 2003 · Corporations

824 A.2d 917 (Del. Ch. 2003)

Updated August 22, 2026

CorporationsDerivative litigationSpecial litigation committeesDirector independenceZapataspecial litigation committeeindependenceimpartiality

Facts

Oracle formed a two-member special litigation committee composed of Professors Hector Garcia-Molina and Joseph Grundfest, both Stanford professors who had joined Oracle's board after the alleged insider trading. Discovery revealed substantial ties between Stanford and the directors under investigation: defendant Boskin was a Stanford professor and had taught Grundfest; Boskin and Grundfest both served as senior fellows and steering committee members at SIEPR; defendant Lucas was a major Stanford donor, chair of SIEPR's advisory board, and had made donations to Stanford Law School and SIEPR; and defendant Ellison and Oracle had made or discussed significant donations benefiting Stanford. The SLC's report did not disclose many of these Stanford-related connections, though it recommended terminating the derivative claims.

Issue

Did Oracle's special litigation committee satisfy its burden under Zapata to show the absence of a material factual question regarding its independence? More specifically, did the SLC members' Stanford-based relationships with the directors under investigation create reasonable doubt about their ability to act with only Oracle's best interests in mind?

Rule

Under Zapata, an SLC seeking termination of derivative litigation bears the burden to persuade the court that its members were independent, acted in good faith, and had reasonable bases for their recommendation. Independence turns on whether a director is, for any substantial reason, incapable of making a decision with only the corporation's best interests in mind; the inquiry focuses on impartiality and objectivity, not merely on domination, control, or financially material ties. If a material factual question creates reasonable doubt about the SLC's independence, the motion to terminate must be denied.

See the holding & full analysis

Create a free KwikCourt account to unlock the rest of this brief — and practice the case.

The court's holding and reasoning
Doctrine tests, pitfalls & exam hypotheticals
10 practice questions + 4 AI-graded essays on this case

Free sample · practice this case

Test yourself

One of 10 multiple-choice questions for this case. Pick an answer to see why.

Crescent Biologics, a Delaware corporation based in San Diego, formed a two-member special litigation committee to decide whether to terminate a derivative suit accusing three directors of self-dealing. One committee member, Nina Patel, is a tenured professor at a university in Chicago; one target director is also a professor there, previously taught Patel in graduate school, and now serves with her on a university policy institute's steering group.

If the committee moves to terminate the suit under Delaware law, which is the strongest argument against termination at the first step?

Explanation. Under the majority opinion, an SLC bears the burden to persuade the court that no material factual issue calls its independence into doubt. Independence focuses on whether, for any substantial reason, the member may be incapable of deciding solely in the corporation's best interests, and the inquiry centers on impartiality and objectivity, not just domination or economic dependence. Substantial academic and institutional ties can therefore create reasonable doubt without making professors categorically non-independent.